[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-04-23-1":3},{"date":4,"filings":5,"has_more":605,"limit":606,"page":607,"total_count":608},"2026-04-23",[6,14,19,26,31,38,43,48,53,60,67,72,78,85,92,99,106,111,118,123,128,134,141,148,155,160,167,174,179,184,191,197,203,210,217,224,230,235,241,246,252,257,262,269,273,278,285,290,297,304,311,318,325,331,337,343,349,356,361,366,373,380,386,391,398,403,408,415,421,426,433,438,445,450,455,460,465,472,477,483,489,494,501,506,511,516,521,527,532,537,542,549,554,561,566,573,580,587,594,600],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Gujarat Themis Biosyn Limited","2026-04-23T23:58:47.717000","NSE","To Acquire Sanofi's Product Portfolio for €158 Million","69ea650ecc135cc3c5970701","GUJTHEM","*   The company has entered into an agreement to acquire a portfolio of 13 branded generic products from Sanofi for a cash consideration of \u003Cb>€158 million\u003C\u002Fb> (approx. ₹1740 Crores).\n*   This acquisition provides immediate access to over 55 countries, significantly expanding the company's international footprint in Europe, the Middle East, and Africa.\n*   The deal is described as \"asset-light,\" as it excludes manufacturing facilities and employees, focusing only on brands, marketing rights, and inventory.\n*   Strategically, this allows for forward integration with the company's existing API business, aiming to improve profitability across the value chain.\n*   Completion of the transaction is expected by December 31, 2026, subject to antitrust and foreign direct investment approvals.",{"company_name":7,"filing_date":15,"filing_source":9,"headline":16,"id":17,"stock_code":12,"summary_text":18},"2026-04-23T23:53:47.860000","Announces Major Acquisition of Sanofi's Global Portfolio","69ea63e9cc135cc3c59706fa","*   GTBL has entered an agreement to acquire Sanofi's Global Anti-TB and Anti-Infective Product Portfolio for a total value of approximately **€158 Million**.\n*   The acquired portfolio generated revenue of **~€62 Million** in FY2025 and includes 13 established global brands.\n*   This acquisition provides immediate access to **55+ countries**, significantly expanding GTBL's global footprint into Europe, MEA, and Africa.\n*   The transaction is structured as an \"asset-light\" model, with no transfer of manufacturing facilities or employees.\n*   Management expects the deal to be **EPS accretive** and deliver long-term shareholder value.\n*   **Key Condition:** The deal's closure is contingent on receiving necessary antitrust and foreign direct investment (FDI) approvals.",{"company_name":20,"filing_date":21,"filing_source":9,"headline":22,"id":23,"stock_code":24,"summary_text":25},"Tata Teleservices (Maharashtra) Limited","2026-04-23T23:53:47.837000","Strengthens Balance Sheet with ₹ 600 Crore Debt Reduction","69ea63d6548b379cc051b24b","TTML","*   Reduced long-term borrowings by a significant ₹ 600 crores during the financial year, indicating a focus on deleveraging.\n*   Confirmed it is not a 'Large Corporate' under SEBI regulations, providing greater flexibility in its financing strategy.\n*   Maintains a strong 'AA-' investment-grade credit rating, signaling a high degree of safety and very low credit risk.",{"company_name":7,"filing_date":27,"filing_source":9,"headline":28,"id":29,"stock_code":12,"summary_text":30},"2026-04-23T23:53:47.825000","GTBL Announces Transformative Acquisition of Sanofi's Global Portfolio for €158M","69ea63e65f912cbbc08f4596","*   The company has signed a definitive agreement to acquire Sanofi's Global Anti-TB and Anti-Infective Portfolio for a cash consideration of **€158 million**.\n*   The acquired portfolio consists of 13 established brands with net sales of approximately **€62 million** in 2025 and a presence in over 55 countries.\n*   This is a major strategic move for GTBL, marking its forward integration from an API manufacturer into a global, integrated pharmaceutical company.\n*   The transaction is expected to be **EPS accretive** and is projected to close by the end of Q3FY27, subject to regulatory and FDI approvals.",{"company_name":32,"filing_date":33,"filing_source":34,"headline":35,"id":36,"stock_code":12,"summary_text":37},"Gujarat Themis Biosyn Ltd","2026-04-23T23:48:48.917000","BSE","GTBL to Acquire Sanofi's Anti-TB & Anti-Infective Portfolio for €158 Million","69ea62b95f912cbbc08f4590","*   **The Deal**: Gujarat Themis Biosyn Ltd (GTBL) has signed an agreement to acquire a portfolio of established anti-tuberculosis and anti-infective brands from Sanofi for a cash consideration of **€158 million**.\n*   **Acquired Assets**: The acquisition includes 13 branded generic products with marketing rights across 55+ countries. This portfolio generated net sales of approximately **€62 million** in 2025.\n*   **Strategic Shift**: This marks a major forward integration for GTBL, moving from an API manufacturer to a global finished formulations company. The deal does not include any manufacturing facilities or employees.\n*   **Financials & Timeline**: The acquisition will be funded by a mix of debt and equity and is expected to be **EPS accretive**. The transaction is anticipated to close by the end of Q3FY27 (Dec 31, 2026), subject to regulatory approvals.",{"company_name":32,"filing_date":39,"filing_source":34,"headline":40,"id":41,"stock_code":12,"summary_text":42},"2026-04-23T23:48:48.913000","Acquires Sanofi's Global Anti-TB & Anti-Infective Portfolio","69ea62b241a709c546fe9271","*   **The Deal:** GTBL is acquiring Sanofi's Global Anti-TB and Anti-Infective Portfolio for approximately **€158 million**.\n*   **Acquired Assets:** The portfolio includes 13 established global brands with revenues of **~€62 million** (FY25) and a presence in over 55 countries.\n*   **Strategic Rationale:** This is a strategic move for forward integration, global expansion, and margin improvement. The acquisition is expected to be **EPS accretive**.\n*   **Deal Structure:** The transaction is an **asset-light acquisition** (brands, marketing authorizations, inventory) with no transfer of manufacturing facilities or employees.\n*   **Funding:** The acquisition will be funded by a mix of debt and equity.\n*   **Key Condition:** The deal is subject to receiving necessary antitrust and foreign direct investment (FDI) approvals.",{"company_name":7,"filing_date":44,"filing_source":9,"headline":45,"id":46,"stock_code":12,"summary_text":47},"2026-04-23T23:43:47.846000","To Acquire Sanofi's Branded Generics Portfolio for €158M","69ea6192cc135cc3c59706ee","*   **The Deal:** Signed an Asset Purchase Agreement with **Sanofi** to acquire a portfolio of 13 branded generic products in the anti-tuberculosis and anti-infective segments.\n*   **Acquisition Cost:** The transaction is valued at **Euro 158 million**, payable in cash.\n*   **Strategic Expansion:** This asset-light deal provides immediate access to over 55 countries across Europe, the Middle East, and Africa, significantly expanding GTBL's global footprint.\n*   **Financials:** The acquired portfolio generated revenue of approximately **EURO 62 million** in FY25.\n*   **Timeline & Conditions:** The deal is expected to close by the end of December 2026, subject to regulatory and antitrust approvals.",{"company_name":32,"filing_date":49,"filing_source":34,"headline":50,"id":51,"stock_code":12,"summary_text":52},"2026-04-23T23:38:48.933000","Acquires Sanofi's Anti-Infective Portfolio for €158 Million","69ea605b9488adfc758f47ce","*   Signed an Asset Purchase Agreement with Sanofi to acquire a portfolio of 13 branded generic products in the anti-tuberculosis and anti-infective segments.\n*   The total cost of acquisition is **€158 million**, payable in cash. The deal is described as a \"capital-efficient and asset-light expansion\" as it excludes manufacturing facilities and employees.\n*   This acquisition provides immediate access to regulated and semi-regulated markets across more than 55 countries.\n*   The acquired portfolio's revenue was **€62 million** in FY25, a decline from €67 million in FY24. The acquisition price represents a ~2.55x multiple on FY25 sales.\n*   The transaction is expected to close by the end of December 2026, subject to antitrust and other regulatory approvals.",{"company_name":54,"filing_date":55,"filing_source":9,"headline":56,"id":57,"stock_code":58,"summary_text":59},"Sab Events & Governance Now Media Limited","2026-04-23T23:38:47.856000","Insolvency Update: Crucial Creditors' Meeting Scheduled","69ea60501248469de89705d6","SABEVENTS","*   The 5th meeting of the Committee of Creditors (CoC) is scheduled for April 28, 2026.\n*   The company is currently undergoing a Corporate Insolvency Resolution Process (CIRP), representing a high level of risk.\n*   The meeting's agenda is to discuss the eligibility of a \"Resolution Applicant,\" a critical step towards resolving the company's insolvency.\n*   Existing shareholders face a very high risk of significant or total erosion of their investment value as a result of the proceedings.",{"company_name":61,"filing_date":62,"filing_source":34,"headline":63,"id":64,"stock_code":65,"summary_text":66},"Hari Govind International Ltd","2026-04-23T23:33:49.022000","Company Renamed to Popees Baby Care India Ltd","69ea5f249488adfc758f47c6","531971","• The company has officially changed its name from \"Hari Govind International Limited\" to \"Popees Baby Care India Limited\".\n• This change is effective from 22nd April 2026, following approval from the Ministry of Corporate Affairs (MCA).\n• The name change signals a strategic rebranding and a sharpened focus on the baby care products market.\n• The company's Corporate Identification Number (CIN) remains unchanged. The stock's Scrip ID on BSE (HARIGOV) will be updated to reflect the new name.",{"company_name":54,"filing_date":68,"filing_source":9,"headline":69,"id":70,"stock_code":58,"summary_text":71},"2026-04-23T23:33:48.288000","Insolvency Update: 5th Creditors' Meeting Scheduled","69ea5f261248469de89705d1","*   The company is undergoing a Pre-Packaged Insolvency Resolution Process (PPIRP), indicating severe financial distress and high risk for shareholders.\n*   The 5th meeting of the Committee of Creditors (CoC) is scheduled for **Tuesday, April 28, 2026, at 11:00 A.M.**\n*   The meeting's agenda, directed by the National Company Law Tribunal (NCLT), is to discuss the eligibility of a \"Resolution Applicant\" to potentially rescue the company.\n*   The ongoing insolvency proceeding is a major red flag, and the outcome will determine the company's future and the potential for any recovery for creditors and shareholders.",{"company_name":73,"filing_date":74,"filing_source":34,"headline":75,"id":76,"stock_code":58,"summary_text":77},"SAB Events & Governance Now Media Ltd","2026-04-23T23:28:48.591000","Key Creditors' Meeting Scheduled to Discuss Resolution Applicant","69ea5e059488adfc758f47bf","• The 5th meeting of the Committee of Creditors (CoC) is scheduled for Tuesday, April 28, 2026.\n• The main agenda is to discuss the eligibility of a potential Resolution Applicant as part of the company's ongoing insolvency process.\n• The company is currently undergoing a Pre-Packaged Insolvency Resolution Process (PPIRP), which is a major red flag indicating severe financial distress.\n• There is a very high risk for existing shareholders, with the potential for significant equity dilution or a complete write-off of their investment.",{"company_name":79,"filing_date":80,"filing_source":9,"headline":81,"id":82,"stock_code":83,"summary_text":84},"EMA Partners India Limited","2026-04-23T23:28:48.130000","Director Designation Change Announced","69ea5df1548b379cc051b22a","EMAPARTNER","*   Mr. Shekhar Ganapthy has been re-designated from Whole time Director to Non-Executive Non-Independent Director, effective April 23, 2026.\n*   This change marks a significant shift in Mr. Ganapthy's role from day-to-day management to a non-executive, oversight function on the Board.\n*   The filing was made under Regulation 30 of the SEBI (LODR) Regulations, 2015, to disclose the change in Key Managerial Personnel (KMP).",{"company_name":86,"filing_date":87,"filing_source":9,"headline":88,"id":89,"stock_code":90,"summary_text":91},"Viviana Power Tech Limited","2026-04-23T23:28:48.087000","Board to Consider Fundraising via Debt Issue","69ea5df8373ff94e07fe9141","VIVIANA","*   The Board of Directors will meet on April 28, 2026.\n*   The primary agenda is to consider and approve a proposal for fundraising through the issuance of debt securities.\n*   This is a key event for investors, as the company intends to raise capital. Details on the size, terms, and purpose of the debt are expected after the meeting.",{"company_name":93,"filing_date":94,"filing_source":34,"headline":95,"id":96,"stock_code":97,"summary_text":98},"Narayana Hrudayalaya Ltd","2026-04-23T23:18:48.757000","Confirms 'Large Corporate' Status Under SEBI Framework","69ea5c6383759b4678fe9361","NH","• The company is now officially classified as a \"Large Corporate\" under SEBI regulations.\n• This mandates raising at least 25% of its future long-term borrowings through debt securities.\n• It holds a strong credit rating of '[ICRA]AA (Stable)', indicating a high degree of financial safety.\n• Outstanding borrowings were reported at ₹ 1,838.54 Crores as of March 31, 2026.",{"company_name":100,"filing_date":101,"filing_source":34,"headline":102,"id":103,"stock_code":104,"summary_text":105},"Royal Cushion Vinyl Products Ltd","2026-04-23T23:13:49.886000","FY26 Compliance Update: Not a 'Large Corporate'","69ea5a76a27701906497081f","526193","*   The company has filed its annual disclosure, confirming it does **not** qualify as a \"Large Corporate\" under SEBI regulations for the financial year ending March 31, 2026.\n*   Outstanding borrowings as of March 31, 2026, were reported at ₹27.70 Crores.\n*   Crucially, the company disclosed that it was **\"Not Rated\"** by any credit rating agency during the previous financial year, a key point for investors assessing credit risk.",{"company_name":79,"filing_date":107,"filing_source":9,"headline":108,"id":109,"stock_code":83,"summary_text":110},"2026-04-23T23:08:47.785000","Revises IPO Spending Plan & Extends Utilization Timeline","69ea595f83759b4678fe9350","*   The company has re-allocated ₹4.66 Crores of its IPO funds, moving the amount from 'Upgrading IT Infrastructure' to 'Augmenting Leadership Team'. Shareholders approved this change.\n*   A significant delay in fund utilization was reported, with only 52.3% (₹31.11 Cr) of the net IPO proceeds used over a year after listing.\n*   The Board has formally extended the timeline for utilizing the remaining funds by an additional year.\n*   The Monitoring Agency's report noted \"no deviation\" from the stated objects but highlighted the cost revision and the delay in implementation.\n*   No funds have been used for the 'Unidentified Inorganic Acquisitions' objective.",{"company_name":112,"filing_date":113,"filing_source":34,"headline":114,"id":115,"stock_code":116,"summary_text":117},"HDFC Life Insurance Company Ltd","2026-04-23T22:58:48.681000","FY26 Results: Weak Growth, Margin Contraction, and a Planned Capital Raise","69ea57119488adfc758f479f","HDFCLIFE","*   **Weak Core Performance:** Value of New Business (VNB) grew only 2% YoY to ₹4,034 crores, while New Business Margin (NBM) contracted by 140 bps to 24.2%, driven by regulatory impacts and cost pressures.\n*   **Market Share Loss:** The company acknowledged losing market share in its key HDFC Bank channel due to \"heightened competitive intensity,\" stating it prioritized profitability over chasing unviable business.\n*   **Capital Raise & Dilution:** The Board approved raising up to ₹1,000 crores through a preferential issue of equity to its promoter, HDFC Bank. This will strengthen solvency but result in dilution for minority shareholders.\n*   **Bright Spot in Protection:** The Retail Protection segment was a standout performer, growing by a robust 43% YoY, driven by post-GST price reductions.\n*   **Dividend Declared:** The Board has recommended a final dividend of ₹2.10 per share for FY26.",{"company_name":79,"filing_date":119,"filing_source":9,"headline":120,"id":121,"stock_code":83,"summary_text":122},"2026-04-23T22:58:47.779000","Announces Share Buyback via Tender Offer","69ea56f660e6549cbc51afd5","*   The company will buy back \u003Cb>7,25,000 Equity Shares\u003C\u002Fb> through a Tender Offer.\n*   The buyback price is set at \u003Cb>₹100.00 per share\u003C\u002Fb>, for a total size of \u003Cb>₹7.25 Crores\u003C\u002Fb>.\n*   The \u003Cb>Record Date\u003C\u002Fb> for shareholders to be eligible to participate is \u003Cb>27-Apr-2026\u003C\u002Fb>.\n*   \u003Cb>Red Flag\u003C\u002Fb>: The filing contains a material inconsistency, stating the post-buyback share count will remain unchanged, which contradicts the process of share extinguishment.",{"company_name":112,"filing_date":124,"filing_source":34,"headline":125,"id":126,"stock_code":116,"summary_text":127},"2026-04-23T22:53:49.676000","Set to Become a Subsidiary of HDFC Bank","69ea55c4548b379cc051b200","• Proposes a preferential issue of ~1.45 crore equity shares to its promoter, HDFC Bank Ltd.\n• Post-issue, HDFC Bank's shareholding will increase to 50.27%.\n• This will officially make HDFC Life a subsidiary of HDFC Bank, a material change in ownership structure.\n• The proposal is subject to shareholder approval via a postal ballot.",{"company_name":129,"filing_date":130,"filing_source":9,"headline":131,"id":132,"stock_code":116,"summary_text":133},"HDFC Life Insurance Company Limited","2026-04-23T22:53:47.944000","FY26 Earnings: Margin Pressure Persists, Board Approves Capital Infusion","69ea55de1248469de89705af","*   Value of New Business (VNB) grew 2% to ₹4,034 Cr, while New Business Margin (NBM) declined 140 bps to 24.2% due to regulatory impacts.\n*   Individual APE grew 7%, driven by strong performance in the proprietary agency channel, which offset a slowdown in bancassurance.\n*   Board approved raising up to ₹1,000 Cr via a preferential issue to HDFC Bank to strengthen solvency and fund growth, leading to potential equity dilution.\n*   Company faces \"heightened competitive intensity,\" leading to a loss of wallet share in the key HDFC Bank channel.\n*   A final dividend of ₹2.10 per share has been recommended.",{"company_name":135,"filing_date":136,"filing_source":9,"headline":137,"id":138,"stock_code":139,"summary_text":140},"Usha Martin Limited","2026-04-23T22:48:48.322000","Board to Consider FY26 Results & Final Dividend","69ea549a373ff94e07fe9123","USHAMART","*   A Board Meeting is scheduled for April 30, 2026.\n*   The agenda includes approving the audited financial results for the quarter and year ended March 31, 2026.\n*   The Board will also consider and recommend a final dividend for the financial year 2025-26.\n*   The trading window for designated persons has been closed since April 1, 2026, and will reopen 48 hours after the results are declared.",{"company_name":142,"filing_date":143,"filing_source":9,"headline":144,"id":145,"stock_code":146,"summary_text":147},"Balrampur Chini Mills Limited","2026-04-23T22:48:48.033000","Board Approves ₹650 Crore Capital Raise","69ea54a5dc0df4d70851b120","BALRAMCHIN","*   The Board of Directors has approved a plan to raise a total of \u003Cb>₹650 Crores\u003C\u002Fb> through a combination of equity and debt.\n*   This includes raising \u003Cb>₹450 Crores\u003C\u002Fb> via a preferential issue of 93.16 lakh equity shares at a price of \u003Cb>₹483 per share\u003C\u002Fb>.\n*   The preferential allotment will be made to promoter group entities and prominent institutional investors, resulting in an equity dilution of approximately \u003Cb>4.4%\u003C\u002Fb>.\n*   The company also received enabling approval to raise up to \u003Cb>₹200 Crores\u003C\u002Fb> by issuing Non-Convertible Debentures (NCDs).\n*   An Extra-ordinary General Meeting (EGM) is scheduled for \u003Cb>20 May 2026\u003C\u002Fb> to seek shareholder approval for the preferential issue.",{"company_name":149,"filing_date":150,"filing_source":9,"headline":151,"id":152,"stock_code":153,"summary_text":154},"Lux Industries Limited","2026-04-23T22:48:47.999000","Lux Industries to Launch New Wholly-Owned Subsidiary","69ea548e1248469de89705ab","LUXIND","*   The company announced plans to incorporate a new, wholly-owned subsidiary to expand its core business.\n*   The new subsidiary will focus on the manufacturing and trading of garments and hosiery products.\n*   The initial investment for the acquisition will be ₹ 5,00,000 (Rupees Five Lakhs) in cash.\n*   Lux Industries will subscribe to 100% of the new entity's share capital.",{"company_name":129,"filing_date":156,"filing_source":9,"headline":157,"id":158,"stock_code":116,"summary_text":159},"2026-04-23T22:48:47.965000","HDFC Bank Set to Become Majority Shareholder","69ea54a49488adfc758f4791","*   The company proposes to issue over 1.45 crore equity shares to its promoter, HDFC Bank, on a preferential basis.\n*   Following the issue, HDFC Bank's shareholding in the company will increase to 50.27%.\n*   This will officially make HDFC Life Insurance a subsidiary of HDFC Bank Limited.\n*   The proposal is subject to shareholder approval via a Postal Ballot.",{"company_name":161,"filing_date":162,"filing_source":34,"headline":163,"id":164,"stock_code":165,"summary_text":166},"NIIT Learning Systems Ltd","2026-04-23T22:43:48.415000","Challenges Income Tax Demand","69ea537083759b4678fe932d","NIITMTS","*   The company has received a tax demand from the Income Tax Department for the Assessment Year 2023-24, which it is contesting.\n*   Management attributes the demand to \"apparent mistakes\" and \"short credit of prepaid taxes\" in the tax computation.\n*   To dispute the order, the company has filed for rectification and has also filed an appeal with the Commissioner of Income Tax (Appeals).\n*   The specific monetary value of the demand was not disclosed, but this represents a potential financial liability and a red flag for investors to monitor.",{"company_name":168,"filing_date":169,"filing_source":34,"headline":170,"id":171,"stock_code":172,"summary_text":173},"Choice International Ltd","2026-04-23T22:43:48.408000","₹693 Cr Warrant Issue Fully Converted & Utilized","69ea53826a5edce36d8f4663","CHOICEIN","• As of March 31, 2026, all 2.31 crore share warrants have been converted to equity shares, and the entire issue size of ₹693.63 Crores has been fully utilized.\n• The Monitoring Agency, India Ratings & Research, has confirmed there is no deviation in the use of proceeds from the objects stated in the offer document.\n• The company strategically re-allocated funds, increasing its investment in subsidiaries by ₹45.45 Crores over the planned amount, which was within permissible limits.\n• During the quarter, a significant investment of ₹65 Crores was made in its subsidiary, Choice Equity Broking Private Limited, as part of this utilization.",{"company_name":149,"filing_date":175,"filing_source":9,"headline":176,"id":177,"stock_code":153,"summary_text":178},"2026-04-23T22:43:48.065000","Promoter Family Announces Major Restructuring Plan to Demerge Company","69ea53755f912cbbc08f455b","*   The promoter family (Todi Family) has signed a Family Settlement Agreement (FSA) to amicably divide the business.\n*   The agreement proposes a demerger of Lux Industries into three separate, publicly listed companies.\n*   Post-demerger, each company will be managed by a different branch of the Todi family, with a clear division of major brands (like Lux Cozi, Lux Venus, GenX) and manufacturing assets.\n*   There is **no immediate change** in the management or control of the company. The proposed demerger is subject to future regulatory and shareholder approvals.\n*   Existing shareholders are expected to receive shares in the two new companies upon completion of the demerger.",{"company_name":79,"filing_date":180,"filing_source":9,"headline":181,"id":182,"stock_code":83,"summary_text":183},"2026-04-23T22:43:48.029000","Board Approves ₹7.25 Crore Share Buy-back","69ea53719488adfc758f4787","*   The Board has approved a buy-back of 725,000 equity shares, representing approx. 3.12% of the company's total shares.\n*   The buy-back price is fixed at **₹100 per equity share**.\n*   The total size of the buy-back is **₹7.25 Crores**.\n*   The buy-back will be conducted via a **Tender Offer**.\n*   The Record Date for determining shareholder eligibility is **April 30, 2026**.",{"company_name":185,"filing_date":186,"filing_source":9,"headline":187,"id":188,"stock_code":189,"summary_text":190},"ESAF Small Finance Bank Limited","2026-04-23T22:43:47.870000","Confirms Timely Interest Payment on Bonds","69ea536fa2770190649707f3","ESAFSFB","*   The bank has confirmed the timely payment of interest for its Non-Convertible Securities with ISIN INE818W08164.\n*   The interest payment, which was due on April 23, 2026, was successfully paid on the same date.\n*   A total interest amount of ₹4,30,89,000 was paid to the security holders.\n*   This action demonstrates the company's financial discipline and ability to meet its debt obligations, reinforcing investor confidence.",{"company_name":192,"filing_date":193,"filing_source":9,"headline":194,"id":195,"stock_code":172,"summary_text":196},"Choice International Limited","2026-04-23T22:43:47.812000","₹693.63 Cr Preferential Issue Fully Utilized & Warrants Converted","69ea5380373ff94e07fe911f","*   The company has fully utilized the entire ₹ 693.63 Crores raised from its preferential issue of warrants as of 31 March 2026.\n*   All warrants from the issue have now been converted into equity shares, marking the completion of the fundraising and dilution process.\n*   The majority of the proceeds (₹ 645.45 Crores) were strategically invested in subsidiaries and associate companies.\n*   During the quarter, a key transaction was a ₹ 65 Crore loan to its subsidiary, Choice Equity Broking Private Limited.\n*   The Monitoring Agency confirmed that the funds were used in line with the stated objectives, with no deviations reported.",{"company_name":198,"filing_date":199,"filing_source":9,"headline":200,"id":201,"stock_code":165,"summary_text":202},"NIIT Learning Systems Limited","2026-04-23T22:43:47.791000","Contests Income Tax Demand for AY 2023-24","69ea536d60e6549cbc51afc8","*   The company has filed an appeal against a tax demand notice from the Income Tax Department for the Assessment Year 2023-24.\n*   Management attributes the demand to \"apparent mistakes\" and \"short credit of prepaid taxes\" during the assessment process.\n*   In response, NIIT has filed both an appeal with the Commissioner of Income Tax (Appeals) and an application for rectification.\n*   The filing does not disclose the monetary value of the tax demand, which is a key piece of missing information for investors.",{"company_name":204,"filing_date":205,"filing_source":9,"headline":206,"id":207,"stock_code":208,"summary_text":209},"Orient Cement Limited","2026-04-23T22:38:47.800000","Shareholder Alert: Claim Your Unclaimed Dividends!","69ea52545f912cbbc08f4556","ORIENTCEM","*   The company has launched the \"Saksham Niveshak\" campaign for shareholders to claim unpaid\u002Funclaimed dividends.\n*   This initiative aims to prevent the mandatory transfer of these funds to the government's Investor Education and Protection Fund (IEPF).\n*   The campaign runs from April 1, 2026, to July 9, 2026.\n*   Shareholders are required to update their KYC and bank details by submitting the necessary forms to the company's RTA, KFin Technologies Limited.",{"company_name":211,"filing_date":212,"filing_source":34,"headline":213,"id":214,"stock_code":215,"summary_text":216},"Hexaware Technologies Ltd","2026-04-23T22:33:48.669000","Key Director Resigns Following Carlyle Group Exit","69ea51219488adfc758f4779","HEXT","*   Mr. Shawn Devilla has resigned as a Non-Executive Non-Independent Director, effective April 22, 2026.\n*   The resignation is directly linked to his transition away from The Carlyle Group, a significant private equity stakeholder in Hexaware.\n*   This change in board representation from a key investor could signal a future shift in strategy and warrants monitoring.\n*   As a result, Mr. Devilla also ceases to be a member of the Risk Management and Stakeholders Relationship Committees.",{"company_name":218,"filing_date":219,"filing_source":9,"headline":220,"id":221,"stock_code":222,"summary_text":223},"BlueStone Jewellery and Lifestyle Limited","2026-04-23T22:33:48.014000","Appoints New Internal Auditor","69ea510f1248469de897059e","544484","*   The company has appointed Sudit K. Parekh & Co. LLP, Chartered Accountants, as its new Internal Auditor.\n*   The appointment is effective from April 23, 2026.\n*   This change in management was filed under Regulation 30 of the SEBI (LODR) Regulations, 2015.",{"company_name":225,"filing_date":226,"filing_source":9,"headline":227,"id":228,"stock_code":215,"summary_text":229},"Hexaware Technologies Limited","2026-04-23T22:33:47.972000","Director Resigns, Citing New Role and Exit from The Carlyle Group","69ea511ea2770190649707e6","*   Mr. Shawn Devilla has resigned as a Non-Executive Non-Independent Director, effective April 22, 2026.\n*   The reason cited in his letter is a \"transition from The Carlyle Group to a new role,\" which prevents him from dedicating the required time.\n*   His departure creates immediate vacancies on two key board committees: the Stakeholders Relationship Committee and the Risk Management Committee.\n*   This is a notable change for investors, as Mr. Devilla represented major institutional investor The Carlyle Group on the Board.",{"company_name":79,"filing_date":231,"filing_source":9,"headline":232,"id":233,"stock_code":83,"summary_text":234},"2026-04-23T22:33:47.959000","Board Update: Mr. Shekhar Ganapathy Appointed as Whole-time Director","69ea511a373ff94e07fe9118","*   Mr. Shekhar Ganapathy has been re-designated from Non-Executive Director to Whole-time Director, effective April 23, 2026.\n*   The appointment is for a term of up to five years and is subject to shareholder approval at the company's next Annual General Meeting (AGM).\n*   With over 20 years in the IT services industry and expertise in digital strategy, this move signals a strategic focus on enhancing the company's technological capabilities.\n*   The change is seen as a significant enhancement of the executive management team, aiming to drive technology-led growth.",{"company_name":236,"filing_date":237,"filing_source":34,"headline":238,"id":239,"stock_code":208,"summary_text":240},"Orient Cement Ltd","2026-04-23T22:28:48.440000","Attention Shareholders: Claim Unpaid Dividends & Update KYC","69ea4ff083759b4678fe9319","*   The company has launched a 100-day shareholder awareness campaign, \"Saksham Niveshak,\" running from April 1, 2026, to July 9, 2026.\n*   The campaign's goal is to help shareholders claim unpaid dividends from the past 7 years and update their KYC details (PAN, bank account, etc.).\n*   This initiative, requested by the Investor's Education and Protection Fund Authority (IEPFA), aims to prevent unclaimed funds from being transferred to the government's IEPF.\n*   Shareholders are urged to contact the Registrar and Transfer Agent, KFin Technologies, to submit the necessary forms and update their records.",{"company_name":79,"filing_date":242,"filing_source":9,"headline":243,"id":244,"stock_code":83,"summary_text":245},"2026-04-23T22:28:48.139000","Approves ₹7.25 Crore Share Buyback; Reports Mixed FY26 Results","69ea50021248469de8970598","*   \u003Cb>Financials:\u003C\u002Fb> Revenue from operations grew 18.17% YoY, but Profit After Tax (PAT) declined by 2.45% due to higher expenses, indicating margin pressure.\n*   \u003Cb>Share Buyback:\u003C\u002Fb> The Board approved a buyback of up to 7,25,000 shares at a price of \u003Cb>₹100 per share\u003C\u002Fb> via tender offer.\n*   \u003Cb>Promoter Action:\u003C\u002Fb> Promoters have stated they will \u003Cb>not participate\u003C\u002Fb> in the buyback, which is a positive for public shareholders as it may increase the acceptance ratio.\n*   \u003Cb>Profitability:\u003C\u002Fb> Basic Earnings Per Share (EPS) for the year fell sharply by 22.32% to \u003Cb>₹5.29\u003C\u002Fb> from ₹6.81 last year.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The company's credit rating is listed as 'NA' (Not Applicable) despite having debt, which is noted as a significant point of concern.",{"company_name":247,"filing_date":248,"filing_source":34,"headline":249,"id":250,"stock_code":146,"summary_text":251},"Balrampur Chini Mills Ltd","2026-04-23T22:23:49.177000","Board Approves ₹650 Crore Fundraise & Project Expansions","69ea4ed5373ff94e07fe910e","• The Board has approved a significant capital raise of up to \u003Cb>₹650 Crores\u003C\u002Fb>.\n• The fundraise includes a \u003Cb>₹450 Crore preferential issue\u003C\u002Fb> of equity shares and a \u003Cb>₹200 Crore issuance of Non-Convertible Debentures (NCDs)\u003C\u002Fb>.\n• The estimated cost for the ongoing Poly Lactic Acid (PLA) project has been increased by \u003Cb>₹230 Crore\u003C\u002Fb> to a total of ₹3,080 Crore.\n• A new \u003Cb>Lactogypsum Processing Plant\u003C\u002Fb> will be established for ₹160 Crore to add value to the by-products of the PLA project.\n• The preferential allotment will increase the promoter group's shareholding. An Extra-Ordinary General Meeting (EGM) is scheduled for \u003Cb>May 20, 2026\u003C\u002Fb>, for shareholder approval.",{"company_name":247,"filing_date":253,"filing_source":34,"headline":254,"id":255,"stock_code":146,"summary_text":256},"2026-04-23T22:23:49.151000","Board Greenlights ₹650 Cr Fundraising for PLA & New Gypsum Plant","69ea4edc548b379cc051b1d5","*   **Fundraising Plan:** The Board has approved raising up to ₹650 Crore through a ₹450 Crore preferential issue of equity shares and ₹200 Crore via Non-Convertible Debentures (NCDs).\n*   **Preferential Issue Details:** The issue is priced at ₹483 per share. Promoters and promoter groups will invest ~₹193 Crore, signaling strong confidence.\n*   **PLA Project Cost Revision:** The estimated cost for the flagship Poly Lactic Acid (PLA) project has been increased by ₹230 Crore to a revised total of ₹3,080 Crore, citing rising material costs and supply chain issues.\n*   **New Gypsum Plant:** A new Gypsum Processing Plant will be set up for ₹160 Crore to add value by monetizing a by-product from the PLA facility, with production expected by December 2027.\n*   **Shareholder Approval:** An Extra-Ordinary General Meeting (EGM) is scheduled for May 20, 2026, to seek shareholder approval for the proposals.",{"company_name":79,"filing_date":258,"filing_source":9,"headline":259,"id":260,"stock_code":83,"summary_text":261},"2026-04-23T22:23:47.949000","Announces ₹7.25 Cr Share Buyback & FY26 Results","69ea4edd83759b4678fe9313","*   The Board has approved a share buyback of up to 7,25,000 shares at **₹100 per share**, totaling ₹7.25 Crores. The record date is **April 30, 2026**.\n*   Promoters will **not** participate in the buyback, which will increase their post-buyback shareholding from the current 63.71%.\n*   For the full year (FY26), revenue from operations grew **18.17%** year-on-year to ₹87.36 Crores.\n*   Despite revenue growth, Profit Before Tax (PBT) declined by **4.49%** to ₹15.10 Crores, indicating margin pressure.\n*   Basic Earnings Per Share (EPS) for the year decreased by 22.32% to ₹5.29 from ₹6.81 in the previous year.",{"company_name":263,"filing_date":264,"filing_source":34,"headline":265,"id":266,"stock_code":267,"summary_text":268},"Scan Steels Ltd","2026-04-23T22:18:48.838000","Board Meeting to Approve Allotment of 21.44 Lakh New Equity Shares","69ea4d9983759b4678fe930b","511672","• A Board of Directors meeting is scheduled for Monday, April 27, 2026.\n• The main agenda is to approve the allotment of 21,44,239 new equity shares.\n• This allotment arises from the conversion of existing Optionally Convertible Redeemable Preference Shares (OCRPS).\n• The issuance of new shares will result in equity dilution for existing shareholders.",{"company_name":247,"filing_date":264,"filing_source":34,"headline":270,"id":271,"stock_code":146,"summary_text":272},"Announces ₹450 Cr Fundraise for New Gypsum Plant & PLA Project Expansion","69ea4db81248469de897058e","*   The Board has approved raising **₹450 Crore** by issuing new shares on a preferential basis to promoters and institutional investors (including TATA MF, ICICI Prudential) at a price of **₹483 per share**.\n*   A new **Gypsum Processing Plant** will be established with an investment of **₹160 Crore**, funded from the proceeds. Commercial production is expected by Dec 2027.\n*   The capital expenditure for the flagship **Poly Lactic Acid (PLA) project** has been revised upwards by **₹230 Crore** to a new total of ₹3,080 Crore, citing increased material costs and supply chain issues.\n*   The company will also raise up to **₹200 Crore** through Non-Convertible Debentures (NCDs). An EGM is scheduled for **20th May 2026** to seek shareholder approval.",{"company_name":142,"filing_date":274,"filing_source":9,"headline":275,"id":276,"stock_code":146,"summary_text":277},"2026-04-23T22:18:48.009000","Board Approves ₹650 Crore Fundraising for Major Projects","69ea4daccc135cc3c5970692","*   The Board has approved a plan to raise up to **₹650 Crore** through a mix of equity and debt.\n*   This includes a **₹450 Crore** preferential issue of equity shares and a **₹200 Crore** issue of Non-Convertible Debentures (NCDs).\n*   Funds will support the Poly Lactic Acid (PLA) project, whose estimated cost has been revised upwards by **₹230 Crore** to **₹3,080 Crore**.\n*   The company will also establish a new **₹160 Crore** Gypsum Processing Plant to add value to by-products from the PLA facility.\n*   An Extra-Ordinary General Meeting (EGM) is scheduled for **May 20, 2026**, to seek shareholder approval for the proposals.",{"company_name":279,"filing_date":280,"filing_source":34,"headline":281,"id":282,"stock_code":283,"summary_text":284},"Toyam Sports Ltd","2026-04-23T22:13:48.547000","Reports Zero Revenue, Soaring Losses & Severe Regulatory Issues","69ea4c8d41a709c546fe920d","538607","*   \u003Cb>Financial Collapse:\u003C\u002Fb> The company reported zero income from operations in Q3 FY26. Consolidated net loss for the nine months widened by 210% to ₹1,523.14 Lakhs, driven by its subsidiaries.\n*   \u003Cb>Severe Audit Warning:\u003C\u002Fb> Auditors issued a \"Repetitive Qualified Opinion,\" flagging major issues like potential illegal operation as an unregistered NBFC and failure to pay statutory dues (TDS, Professional Tax).\n*   \u003Cb>Regulatory Probes:\u003C\u002Fb> The company is under investigation by SEBI, and the Enforcement Directorate (ED) has frozen some of its shares. The financial impact is currently \"not ascertainable.\"\n*   \u003Cb>Liquidity Crisis:\u003C\u002Fb> Management admitted to a \"shortage of funds\" and an inability to meet its statutory payment obligations due to losses from its T20 cricket league venture.",{"company_name":142,"filing_date":286,"filing_source":9,"headline":287,"id":288,"stock_code":146,"summary_text":289},"2026-04-23T22:13:47.630000","To Raise ₹650 Cr; PLA Project Cost Increases","69ea4c7f9488adfc758f475f","*   The Board has approved a major capital raise of approx. **₹650 Crores** (**₹450 Cr** via Equity and **₹200 Cr** via Debt).\n*   The equity will be raised through a preferential issue of 93.16 lakh shares at **₹483 per share** to promoters and institutional investors.\n*   The Board has revised the cost estimate for its flagship **Poly Lactic Acid (PLA) project**, increasing it by **₹230 Crore** to a new total of **₹3,080 Crore**, citing rising material costs and supply chain issues.\n*   A new **Gypsum Processing Plant** will be established with a project cost of up to **₹160 Crore** to monetize a by-product from the PLA facility.\n*   An **Extra-Ordinary General Meeting (EGM)** is scheduled for **May 20, 2026**, to seek shareholder approval for the preferential issue.",{"company_name":291,"filing_date":292,"filing_source":34,"headline":293,"id":294,"stock_code":295,"summary_text":296},"UTI Asset Management Company Ltd","2026-04-23T22:03:48.258000","Q4 & FY26 Earnings Call Audio Recording Now Available","69ea4a131248469de8970581","UTIAMC","*   UTI AMC has made the audio recording of its earnings conference call available on its corporate website.\n*   The call discusses the financial results for the quarter and financial year ended March 31, 2026.\n*   This filing is a procedural compliance update under SEBI (LODR) Regulations to ensure transparency.\n*   Investors seeking substantive information on performance and management commentary must listen to the audio recording.\n*   The recording can be accessed at: `https:\u002F\u002Fwww.utimf.com\u002Famc-shareholders\u002Finvestors-updates-presentations-conference-calls`",{"company_name":298,"filing_date":299,"filing_source":9,"headline":300,"id":301,"stock_code":302,"summary_text":303},"AVG Logistics Limited","2026-04-23T22:03:47.959000","Board to Consider Fundraising Proposal","69ea4a0d60e6549cbc51afa6","AVG","*   The Board of Directors will meet on **28 April 2026** to consider a proposal for raising funds.\n*   Potential methods include a **Rights Issue** or \"any other method,\" with the final decision to be made at the meeting.\n*   The trading window for the company's securities is closed from **01 April 2026 to 02 June 2026**.",{"company_name":305,"filing_date":306,"filing_source":9,"headline":307,"id":308,"stock_code":309,"summary_text":310},"Rajputana Industries Limited","2026-04-23T22:03:47.955000","Shareholder Vote on ₹15 Crore Loan to Promoter Group","69ea4a0aa2770190649707c0","RAJINDLTD","*   The company is seeking shareholder approval via a postal ballot for a material related party transaction.\n*   The proposal is to grant a loan of \u003Cb>₹15 Crores\u003C\u002Fb> to \u003Cb>Shera Metal Private Limited\u003C\u002Fb>, a \"Promoter Group Company\".\n*   This transaction carries a potential conflict of interest and requires shareholder scrutiny regarding the use of company funds for a promoter-related entity.\n*   E-voting for the resolution is scheduled from \u003Cb>24 April 2026\u003C\u002Fb> to \u003Cb>23 May 2026\u003C\u002Fb>.",{"company_name":312,"filing_date":313,"filing_source":34,"headline":314,"id":315,"stock_code":316,"summary_text":317},"Inventurus Knowledge Solutions Ltd","2026-04-23T21:58:49.696000","To Acquire TruBridge in All-Cash Deal","69ea48f2a2770190649707b9","IKS","*   Inventurus Knowledge Solutions' U.S. subsidiary has entered a definitive agreement to acquire U.S.-based TruBridge, Inc. (NASDAQ: TBRG).\n*   The transaction is an all-cash deal where TruBridge shareholders will receive **$26.25 in cash for each share**.\n*   The acquisition will be financed primarily through new debt, including a term loan underwritten by Citibank, JPMorganChase, and Deutsche Bank.\n*   This strategic move is aimed at expanding into the \"vital rural and community hospital market\" in the United States.\n*   The deal is expected to close in Q3 2026, subject to customary approvals, including from TruBridge and IKS Health shareholders, and U.S. regulators.\n*   **Key Risk:** The use of significant debt to fund the purchase will increase the company's financial leverage and associated risk profile.",{"company_name":319,"filing_date":320,"filing_source":34,"headline":321,"id":322,"stock_code":323,"summary_text":324},"Rossari Biotech Ltd","2026-04-23T21:58:49.669000","Reschedules Major Capacity Expansion Project","69ea48ea83759b4678fe92f1","ROSSARI","*   The company is rescheduling a significant capacity expansion project at its material subsidiaries, Unitop Chemicals and Tristar Intermediates, which was first announced a year ago.\n*   The reason cited is \"evolving business requirements and market conditions.\"\n*   The project will now be implemented in a phased manner over the next two years.\n*   This is a material development that may signal a change in the company's near-term growth outlook and is considered a potential red flag for investors.",{"company_name":326,"filing_date":327,"filing_source":9,"headline":328,"id":329,"stock_code":323,"summary_text":330},"Rossari Biotech Limited","2026-04-23T21:58:47.956000","Major Capex Project Rescheduled","69ea48ef373ff94e07fe90f7","*   The planned capacity expansion at subsidiaries Unitop Chemicals Private Limited and Tristar Intermediates Private Limited is being rescheduled.\n*   The project will now be implemented in a phased manner over the next two years, a significant change from the original plan announced on 24 April 2025.\n*   Management cites \"evolving business requirements and market conditions\" as the reason for the re-evaluation.\n*   This delay is a material development for investors, as it adjusts the timeline for future growth drivers and signals a more cautious approach.",{"company_name":332,"filing_date":333,"filing_source":34,"headline":334,"id":335,"stock_code":302,"summary_text":336},"AVG Logistics Ltd","2026-04-23T21:53:48.680000","Board Meeting to Discuss Fundraising Proposal","69ea47bea2770190649707b1","• A Board of Directors meeting is scheduled for April 28, 2026, to consider a proposal for raising funds.\n• The company is exploring a rights issue or other methods for this capital infusion.\n• This action could lead to a dilution of existing shareholding.\n• The trading window will continue to remain closed for designated persons.",{"company_name":338,"filing_date":339,"filing_source":9,"headline":340,"id":341,"stock_code":295,"summary_text":342},"UTI Asset Management Company Limited","2026-04-23T21:53:47.780000","Q4 & FY26 Earnings Call Audio Now Available","69ea47b983759b4678fe92ea","*   The company has made the audio recording of its earnings conference call, held on April 23, 2026, available on its corporate website.\n*   The call discusses the financial results for the quarter and financial year ended March 31, 2026.\n*   This filing is a procedural notification to the stock exchanges as per SEBI regulations.\n*   The document itself does not contain financial data; investors seeking details must listen to the audio recording provided.",{"company_name":344,"filing_date":345,"filing_source":9,"headline":346,"id":347,"stock_code":316,"summary_text":348},"Inventurus Knowledge Solutions Limited","2026-04-23T21:53:47.776000","IKS Health Announces Major US Acquisition of TruBridge, Inc.","69ea47cc5f912cbbc08f4530","*   IKS Health's U.S. subsidiary has entered a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG), a U.S. healthcare technology provider.\n*   The transaction is an all-cash offer of $26.25 for each share of TruBridge common stock.\n*   The acquisition will be financed primarily through new debt, which will materially increase the company's financial leverage.\n*   This strategic move aims to expand IKS Health's footprint into the U.S. rural and community hospital market, creating a combined entity supporting over 2,000 healthcare organizations.\n*   The deal is expected to close in the third calendar quarter of 2026, subject to shareholder and regulatory approvals.",{"company_name":350,"filing_date":351,"filing_source":34,"headline":352,"id":353,"stock_code":354,"summary_text":355},"Sai Life Sciences Ltd","2026-04-23T21:48:48.113000","Issues 2.44 Lakh Shares to Employees Under ESOP","69ea469541a709c546fe91f1","SAILIFE","*   The Board has allotted **2,44,281 equity shares** to employees upon the exercise of vested stock options under its ESOP schemes.\n*   The company raised total funds of **₹3.38 crore** from this exercise.\n*   Post-allotment, the total issued share capital of the company has increased to **212,023,515 shares**.\n*   This issuance results in a minor equity dilution of approximately **0.115%** for existing shareholders.",{"company_name":247,"filing_date":357,"filing_source":34,"headline":358,"id":359,"stock_code":146,"summary_text":360},"2026-04-23T21:43:48.487000","Board Approves ₹650 Crore Fundraising for Strategic Expansion","69ea457e83759b4678fe92de","*   The Board has approved raising up to **₹650 Crore** through a preferential issue of equity shares (₹450 Crore) and Non-Convertible Debentures (₹200 Crore).\n*   The capital will fund a major diversification into a **Poly Lactic Acid (PLA) project**, whose estimated cost has been revised upwards by ₹230 Crore to **₹3,080 Crore**.\n*   A new **Gypsum Processing Plant** will also be established at a cost of **₹160 Crore** to process by-products from the PLA facility.\n*   An Extra-Ordinary General Meeting (EGM) will be held on **May 20, 2026**, to seek shareholder approval for the preferential share issue.",{"company_name":305,"filing_date":362,"filing_source":9,"headline":363,"id":364,"stock_code":309,"summary_text":365},"2026-04-23T21:43:47.713000","Seeks Nod for ₹15 Crore Unsecured Loan to Related Party","69ea456f1248469de897056d","• The company is seeking shareholder approval to grant an unsecured inter-corporate loan of up to ₹15 Crore to a related party, Shera Metal Private Limited.\n• This transaction involves a conflict of interest, as two key directors of Rajputana Industries (Mrs. Shivani Sheikh and Mr. Sheikh Naseem) are also interested in the borrowing entity.\n• While the company states the transaction is at arm's length, the unsecured nature of such a large loan is a material point for investor consideration.\n• Shareholders can vote electronically on the proposal from April 24, 2026, to May 23, 2026.",{"company_name":367,"filing_date":368,"filing_source":9,"headline":369,"id":370,"stock_code":371,"summary_text":372},"Infollion Research Services Limited","2026-04-23T21:43:47.707000","Declaration on Corporate Governance Reporting","69ea4567a2770190649707a2","INFOLLION","*   The company has filed a declaration stating it is exempt from submitting the quarterly corporate governance report required under SEBI regulations.\n*   This exemption is claimed because the company's securities are listed on the SME Platform of the National Stock Exchange (NSE), as permitted under Regulation 15(2)(b).\n*   As a result, the company is not required to comply with several key governance regulations that apply to mainboard-listed companies, including rules on board composition, audit committees, and risk management.\n*   Investors should note this represents a material difference in the governance structure compared to a mainboard company.",{"company_name":374,"filing_date":375,"filing_source":9,"headline":376,"id":377,"stock_code":378,"summary_text":379},"Aditya Birla Sun Life AMC Limited","2026-04-23T21:43:47.680000","Proposes Final Dividend of ₹25.50 Per Share","69ea455c5f912cbbc08f4527","ABSLAMC","*   The Board has recommended a final dividend of **₹25.50 per equity share** (face value of ₹5.00) for the financial year 2025-2026.\n*   This dividend is **subject to shareholder approval** at the upcoming Annual General Meeting (AGM).\n*   The Record Date to determine shareholder eligibility and the date of the AGM will be announced in due course.",{"company_name":381,"filing_date":382,"filing_source":9,"headline":383,"id":384,"stock_code":354,"summary_text":385},"Sai Life Sciences Limited","2026-04-23T21:38:47.568000","Allots 2.44 Lakh Equity Shares Under ESOPs","69ea443c60e6549cbc51af95","*   The Board approved the allotment of **2,44,281 equity shares** to employees upon the exercise of stock options under its ESOP 2008 and MESOP 2018 plans.\n*   This exercise results in a total cash inflow of **₹3.38 Crores** for the company.\n*   The company's total issued share capital will increase to **₹21,20,23,515** (representing 212,023,515 shares).\n*   The new allotment results in a minor equity dilution of approximately **0.115%** for existing shareholders.",{"company_name":247,"filing_date":387,"filing_source":34,"headline":388,"id":389,"stock_code":146,"summary_text":390},"2026-04-23T21:33:48.590000","Approves ₹650 Crore Fundraising for Major Projects","69ea43249488adfc758f4732","*   The Board has approved a fundraising plan of up to **₹650 Crore** through a mix of equity and debt.\n*   Plans to raise **~₹450 Crore** by issuing 93.16 lakh equity shares on a preferential basis at ₹483 per share to promoters and institutional investors.\n*   Approved the issuance of Non-Convertible Debentures (NCDs) to raise up to **₹200 Crore**.\n*   The capital expenditure (CAPEX) for the Poly Lactic Acid (PLA) project has been revised upwards by ₹230 Crore to **₹3,080 Crore** due to cost escalations.\n*   A new Gypsum Processing Plant will be set up with an investment of up to **₹160 Crore** to add value to a by-product from the PLA plant.\n*   An Extra-Ordinary General Meeting (EGM) will be held on May 20, 2026, to seek shareholder approval for the proposals.",{"company_name":392,"filing_date":393,"filing_source":9,"headline":394,"id":395,"stock_code":396,"summary_text":397},"Sheela Foam Limited","2026-04-23T21:28:49.442000","Kurlon Merger Update: Fractional Shares Sold","69ea41e341a709c546fe91d8","SFL","*   As a final step in the merger with Kurlon Enterprise Limited, the company has sold the consolidated fractional shares in the open market.\n*   Eligible former shareholders of Kurlon will receive a cash payout from the sale proceeds, corresponding to their fractional entitlement.\n*   This action is a standard procedural step, confirming the administrative integration from the merger is being concluded as planned.",{"company_name":374,"filing_date":399,"filing_source":9,"headline":400,"id":401,"stock_code":378,"summary_text":402},"2026-04-23T21:28:49.348000","Q4 & FY26 Earnings Call Recording Now Available","69ea41dd83759b4678fe92c6","*   The company has submitted the audio recording of its Earnings Conference Call for the quarter and financial year ended March 31, 2026.\n*   This filing is a procedural notice to comply with SEBI regulations and does not contain any financial data or management commentary itself.\n*   Investors seeking substantive information must refer to the actual audio recording, which is now available on the company's website.",{"company_name":135,"filing_date":404,"filing_source":9,"headline":405,"id":406,"stock_code":139,"summary_text":407},"2026-04-23T21:28:49.339000","Q4 & FY26 Earnings Call Date Announced","69ea41e7548b379cc051b18e","*   The company has scheduled its Q4 & FY26 Earnings Conference Call for analysts and investors.\n*   The call will take place on Thursday, 30th April 2026, at 4:30 PM IST.\n*   Financial results for the quarter and year ended March 31, 2026, will also be declared on this date.\n*   This filing is a routine corporate announcement and no red flags were identified.",{"company_name":409,"filing_date":410,"filing_source":9,"headline":411,"id":412,"stock_code":413,"summary_text":414},"Hindustan Unilever Limited","2026-04-23T21:28:49.207000","Board Meeting to Consider FY26 Results and Final Dividend","69ea41e11248469de897055e","HINDUNILVR","• A meeting of the Board of Directors is scheduled for Thursday, 30th April, 2026.\n• The agenda includes considering the Audited Financial Results for the year ended 31st March, 2026.\n• The Board will also consider and recommend a Final Dividend for the financial year 2025-26.",{"company_name":416,"filing_date":417,"filing_source":34,"headline":418,"id":419,"stock_code":396,"summary_text":420},"Sheela Foam Ltd","2026-04-23T21:28:49.033000","Finalizes Kurlon Merger with Fractional Share Sale","69ea41e3cc135cc3c5970659","*   Marks the final procedural step in the amalgamation of Kurlon Enterprise Limited with Sheela Foam.\n*   Fractional shares resulting from the merger have been sold in the open market on April 22, 2026.\n*   Eligible former shareholders of Kurlon Enterprise Limited who were entitled to fractional shares will now receive a cash payout.\n*   This action completes the share-related formalities of the merger, allowing the company to focus on business integration.",{"company_name":312,"filing_date":422,"filing_source":34,"headline":423,"id":424,"stock_code":316,"summary_text":425},"2026-04-23T21:28:48.938000","IKS Health to Acquire US-based TruBridge in a $557 Million Deal","69ea420560e6549cbc51af8e","*   **The Deal:** IKS Health has entered a definitive agreement to acquire 100% of TruBridge, Inc., a US-listed company, in a transaction with a bid Enterprise Value of **$557 Million**.\n*   **Funding:** The acquisition will be financed through an initial debt of approximately **$600 Million**. Post-acquisition, leverage is expected to be at or below 3x EBITDA of the combined entity.\n*   **Financial Impact:** The transaction is expected to be **Profit After Tax (PAT) and Earnings Per Share (EPS) accretive starting FY27**, even before factoring in any synergies.\n*   **Strategic Rationale:** The acquisition aims to create an integrated \"Operating System for Healthcare\" and unlocks a significant **$575 M+ cross-sell opportunity** within TruBridge's client base of US rural and community hospitals.\n*   **Combined Entity:** The proforma combined revenue for Jan-Dec 2025 is estimated at **$698 Million**, with a combined Adjusted EBITDA of **$186 Million**.\n*   **Future Outlook:** Management has shared a long-term vision to grow EBITDA from ≈₹1000 Crores (LTM Dec 2025) to ≈**₹3000 Crores by FY30**.",{"company_name":427,"filing_date":428,"filing_source":34,"headline":429,"id":430,"stock_code":431,"summary_text":432},"Mitsu Chem Plast Ltd","2026-04-23T21:28:48.692000","Board Meeting Scheduled to Discuss Financials & Dividend","69ea41d6a27701906497078c","540078","*   The Board of Directors will meet on Saturday, May 02, 2026.\n*   The agenda includes considering the audited financial results for the quarter and year ended March 31, 2026.\n*   The Board will also consider and recommend a final dividend for the financial year 2025-26.\n*   The trading window is closed for designated persons until 48 hours after the results are declared.",{"company_name":434,"filing_date":428,"filing_source":34,"headline":435,"id":436,"stock_code":378,"summary_text":437},"Aditya Birla Sun Life AMC Ltd","Earnings Call Recording for Q4 & FY26 Now Available","69ea41df373ff94e07fe90de","*   The company has provided the audio recording of its earnings conference call held on April 23, 2026.\n*   The call discussed the audited financial results for the quarter and financial year ended March 31, 2026.\n*   This filing is a procedural notification; it does not contain financial data. Investors must listen to the audio recording for performance details and management outlook.",{"company_name":439,"filing_date":440,"filing_source":34,"headline":441,"id":442,"stock_code":443,"summary_text":444},"Hindustan Unilever Ltd","2026-04-23T21:28:48.557000","Board Meeting on April 30 to Consider Final Dividend & FY26 Results","69ea41de9488adfc758f4727","HINDZINC","*   A meeting of the Board of Directors is scheduled for **Thursday, 30th April, 2026**.\n*   The Board will consider the Audited Financial Results for the quarter and financial year ended 31st March, 2026.\n*   The Board will also consider and recommend a **Final Dividend**, if any, for the financial year 2025-26.",{"company_name":247,"filing_date":446,"filing_source":34,"headline":447,"id":448,"stock_code":146,"summary_text":449},"2026-04-23T21:23:48.574000","Announces ₹650 Cr+ Fundraising for Major Expansion into Bioplastics","69ea40be60e6549cbc51af8a","*   The Board has approved raising up to ₹650 Crore through a preferential equity issue (₹450 Cr) and Non-Convertible Debentures (₹200 Cr).\n*   The preferential issue at ₹483\u002Fshare includes promoters and institutional investors like TATA Small Cap Fund and 360 One Pipe Fund.\n*   The estimated cost for the flagship Poly Lactic Acid (PLA) project has been revised upwards by ₹230 Crore to a total of ₹3,080 Crore.\n*   A new Gypsum Processing Plant will be established for ₹160 Crore to monetize by-products from the PLA facility.\n*   An Extra-Ordinary General Meeting (EGM) is scheduled for May 20, 2026, to seek shareholder approval for the equity issuance.",{"company_name":142,"filing_date":451,"filing_source":9,"headline":452,"id":453,"stock_code":146,"summary_text":454},"2026-04-23T21:23:48.349000","Board Approves ₹650 Crore Fundraise for Strategic Diversification","69ea40ca6a5edce36d8f460e","*   The Board has approved raising a total of ~₹650 Crore through a preferential issue of equity shares (~₹450 Crore) and Non-Convertible Debentures (up to ₹200 Crore).\n*   Funds are earmarked for a new ₹160 Crore Gypsum Processing Plant and to support the ongoing Poly Lactic Acid (PLA) project.\n*   The cost for the flagship PLA project has been revised upwards by ₹230 Crore (~8.1%) to ₹3,080 Crore, citing rising material costs and supply chain issues.\n*   The preferential issue will increase the stake of the promoter group, who are participating in the fundraising, signaling confidence.\n*   An Extra-Ordinary General Meeting (EGM) will be held on May 20, 2026, to seek shareholder approval for the capital raise.",{"company_name":149,"filing_date":456,"filing_source":9,"headline":457,"id":458,"stock_code":153,"summary_text":459},"2026-04-23T21:23:48.224000","Approves Plan to Split into Three Separate Companies","69ea40d3548b379cc051b188","• The Board has given in-principle approval for a major demerger to split the business into three separate, publicly listed companies.\n• This restructuring is driven by a Family Settlement Agreement among the promoter Todi family to divide the business and management control.\n• The current listed entity (Lux Industries Ltd.) will continue to operate but will be managed exclusively by the PKT family (Pradip Kumar Todi).\n• The other two promoter branches (AKT and KKT families) will exit the management of the current company and will independently lead the two new demerged companies.\n• Existing shareholders are expected to receive shares in the two new companies. The final scheme and share entitlement ratio are subject to regulatory and shareholder approvals.",{"company_name":344,"filing_date":461,"filing_source":9,"headline":462,"id":463,"stock_code":316,"summary_text":464},"2026-04-23T21:23:48.152000","IKS Health to Acquire TruBridge, Inc. in a Strategic Move","69ea40c31248469de8970557","*   IKS Health has entered a definitive agreement to acquire 100% of TruBridge, Inc., a US-based healthcare technology company, for a Bid Enterprise Value of **$557M**.\n*   The acquisition will be funded through approximately **$600M of debt**, with the combined entity's leverage expected to be around 3x EBITDA.\n*   The strategic goal is to merge IKS's \"System of Action\" with TruBridge's \"System of Record\" (SaaS EHR) to create a comprehensive \"Operating System for Healthcare\".\n*   This deal provides IKS a strong entry into the US rural and community hospital market and is expected to be **PAT and EPS accretive in FY27**.\n*   The transaction is expected to close in **Q2 FY27**, subject to regulatory approvals.\n*   Management has set a long-term \"Vision FY 2030\" to triple EBITDA to approximately **₹3000 Crores**.",{"company_name":466,"filing_date":467,"filing_source":9,"headline":468,"id":469,"stock_code":470,"summary_text":471},"Divyadhan Recycling Industries Limited","2026-04-23T21:23:48","EGM to Approve Migration to NSE Main Board","69ea40b85f912cbbc08f4516","DIVYADHAN","*   An Extra-Ordinary General Meeting (EGM) is scheduled for Friday, 17th May, 2026, to seek shareholder approval for a significant corporate action.\n*   The primary agenda is to approve the migration of the company's shares from the BSE SME Platform to the Main Board of the National Stock Exchange of India (NSE).\n*   This strategic move is a major positive milestone, aimed at increasing share liquidity, enhancing visibility among investors, and improving access to capital markets.\n*   Shareholders can participate through remote e-voting, which will be open from 9:00 A.M. on Tuesday, 14th May, 2026, to 5:00 P.M. on Thursday, 16th May, 2026.",{"company_name":466,"filing_date":473,"filing_source":9,"headline":474,"id":475,"stock_code":470,"summary_text":476},"2026-04-23T21:23:47.973000","EGM Called for Major Changes: Auditor Resignation, Office Relocation, and Fundraising","69ea40afa277019064970785","*   An Extra-ordinary General Meeting (EGM) is scheduled for May 15, 2026, to vote on three significant proposals.\n*   \u003Cb>Auditor Change:\u003C\u002Fb> To appoint a new Statutory Auditor following the resignation of the previous one. \u003Cb>The reason for the resignation was not disclosed, which is a significant red flag.\u003C\u002Fb>\n*   \u003Cb>Office Relocation:\u003C\u002Fb> To approve shifting the company's Registered Office from the State of Maharashtra to the State of Uttar Pradesh.\n*   \u003Cb>Fundraising:\u003C\u002Fb> To issue 36.8 lakh convertible equity warrants on a preferential basis, which will lead to equity dilution for existing shareholders.",{"company_name":478,"filing_date":479,"filing_source":34,"headline":480,"id":481,"stock_code":153,"summary_text":482},"Lux Industries Ltd","2026-04-23T21:18:50.264000","Major Restructuring: Lux Industries to Demerge into Three Separate Companies","69ea3fa95f912cbbc08f4511","*   The Board has given \"in-principle approval\" for a scheme of demerger to split the company into three separate entities.\n*   This decision follows a Family Settlement Agreement (FSA) among the promoter \"Todi Family\" to divide the business and assets.\n*   The business will be trifurcated: the existing Lux Industries Ltd. will continue, and two new companies will be created and subsequently listed on the stock exchanges.\n*   Each of the three promoter family branches (AKT, PKT, KKT) will gain independent management control over one of the three resulting companies.\n*   Existing shareholders are expected to receive shares in the two new companies in addition to their shares in the demerged Lux Industries Ltd.",{"company_name":484,"filing_date":485,"filing_source":34,"headline":486,"id":487,"stock_code":139,"summary_text":488},"Usha Martin Ltd","2026-04-23T21:18:50.145000","Announces Conference Call for Q4 & FY26 Results","69ea3f86373ff94e07fe90d4","*   Usha Martin will host a conference call to discuss its financial results for the quarter and fiscal year ending March 31, 2026.\n*   The call is scheduled for Thursday, 30th April 2026, at 4:30 PM IST.\n*   Senior management will be present to discuss the results and provide an outlook, followed by an interactive Q&A session.\n*   This announcement is a regulatory filing under Regulation 30 of the SEBI (LODR) Regulations, 2015.",{"company_name":279,"filing_date":490,"filing_source":34,"headline":491,"id":492,"stock_code":283,"summary_text":493},"2026-04-23T21:18:49.922000","Reports Zero Revenue & Faces Severe Regulatory Scrutiny","69ea3f98a27701906497077c","*   **Zero Revenue:** The company reported ₹0 in Revenue from Operations for the quarter ended Dec 31, 2025, indicating a complete halt in operational activities.\n*   **Admitted Financial Distress:** Management confirmed a \"shortage of funds\" and an inability to pay statutory liabilities like TDS and professional tax.\n*   **Severe Audit Qualifications:** Auditors issued a \"Repetitive Qualified Conclusion,\" flagging major risks, including the company's failure to assess potential losses on its financial assets and loans.\n*   **Regulatory Probes:** An investigation by the Securities and Exchange Board of India (SEBI) is ongoing, and the Enforcement Directorate (ED) has frozen some of the company's shares.\n*   **Potential RBI Violation:** Auditors highlighted that the company may be required to register as a Non-Banking Financial Company (NBFC) but has not provided information on its compliance status.",{"company_name":495,"filing_date":496,"filing_source":34,"headline":497,"id":498,"stock_code":499,"summary_text":500},"RPG Life Sciences Ltd","2026-04-23T21:18:49.899000","Schedules Earnings Call for Q4 & FY26 Results","69ea3f899488adfc758f4715","RPGLIFE","• The company has scheduled an earnings conference call to discuss its Audited Financial Results for the quarter and year ended March 31, 2026.\n• The call is set for April 30, 2026, at 3:30 PM IST.\n• Management will be represented by Mr. Ashok Nair (Managing Director) and Mr. Amol Lone (Chief Financial Officer).\n• This filing is an intimation for the event; the actual financial results and an investor presentation will be released separately.",{"company_name":427,"filing_date":502,"filing_source":34,"headline":503,"id":504,"stock_code":431,"summary_text":505},"2026-04-23T21:18:49.865000","Board Meeting Scheduled to Announce FY26 Results & Dividend","69ea3f84548b379cc051b17d","*   The Board of Directors will meet on **Saturday, May 02, 2026**.\n*   The primary agenda is to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026.\n*   The Board will also consider and recommend a **final dividend** for the financial year 2025-26.\n*   In compliance with SEBI regulations, the trading window for designated persons is closed from April 1, 2026, until 48 hours after the declaration of financial results.",{"company_name":279,"filing_date":507,"filing_source":34,"headline":508,"id":509,"stock_code":283,"summary_text":510},"2026-04-23T21:18:49.851000","Q3 Results Flag Severe Financial & Regulatory Issues","69ea3fa183759b4678fe92ba","*   **Financial Distress:** Reported zero revenue for Q3 FY26 with a consolidated net loss of ₹617.92 Lakhs.\n*   **Severe Liquidity Crisis:** Management admitted to a \"shortage of funds\" and an inability to pay statutory dues like TDS and professional tax.\n*   **Major Regulatory Scrutiny:** The company is under an ongoing investigation by SEBI, and the Enforcement Directorate (ED) has frozen some of its shares.\n*   **Qualified Audit Opinion:** Auditors issued a repetitive \"Qualified Conclusion,\" flagging multiple risks including failure to account for asset impairment and potential non-compliance with RBI's NBFC regulations.",{"company_name":149,"filing_date":512,"filing_source":9,"headline":513,"id":514,"stock_code":153,"summary_text":515},"2026-04-23T21:13:48.892000","To Split Business into Three Listed Entities","69ea3e715f912cbbc08f450b","*   The promoter family (Todi Family) has entered into a Family Settlement Agreement to realign ownership and management of the business.\n*   To implement this, the Board has given in-principle approval for a demerger that will split the company into three separate entities.\n*   The existing company, Lux Industries Ltd., will continue to be listed and will be managed by the Pradip Kumar Todi (PKT) family, controlling brands like Lux Venus and Lyra.\n*   Two new companies will be created and subsequently listed, managed by the other two promoter family branches, controlling brands like Lux Cozi, ONN, and GenX.\n*   This is a material event for shareholders, who are expected to receive shares in the two new companies. The final terms and share ratio are yet to be announced.",{"company_name":142,"filing_date":517,"filing_source":9,"headline":518,"id":519,"stock_code":146,"summary_text":520},"2026-04-23T21:13:48.720000","To Raise ₹650 Crore for PLA Project Expansion & New Gypsum Plant","69ea3e68548b379cc051b173","*   Announced a major fundraising plan of approx. **₹650 Crore**, comprising **₹450 Crore** through a preferential equity issue and **₹200 Crore** via Non-Convertible Debentures (NCDs).\n*   The capital expenditure for its upcoming Poly Lactic Acid (PLA) project has been revised upwards by **₹230 Crore** to a new total of **₹3,080 Crore**, citing rising material costs and supply chain issues.\n*   Approved the establishment of a new **Gypsum Processing Plant for ₹160 Crore** to convert a by-product from the PLA facility into value-added gypsum boards.\n*   The preferential equity issue at **₹483 per share** will be allotted to promoters and institutional investors, leading to equity dilution and an increase in promoter shareholding.\n*   An Extra-Ordinary General Meeting (EGM) will be held on **May 20, 2026**, to seek shareholder approval for the fundraising.",{"company_name":522,"filing_date":523,"filing_source":9,"headline":524,"id":525,"stock_code":499,"summary_text":526},"RPG Life Sciences Limited","2026-04-23T21:13:48.671000","Announces Q4 & FY26 Earnings Call","69ea3e57373ff94e07fe90ce","*   The company has scheduled its earnings conference call to discuss the Audited Financial Results for the quarter and year ended March 31, 2026.\n*   \u003Cb>Date & Time:\u003C\u002Fb> Thursday, April 30, 2026, at 3:30 PM IST.\n*   \u003Cb>Attendees:\u003C\u002Fb> Mr. Ashok Nair (Managing Director) and Mr. Amol Lone (Chief Financial Officer) will represent the company.\n*   \u003Cb>Purpose:\u003C\u002Fb> This provides an opportunity for investors and analysts to engage with management regarding financial performance and future outlook.\n*   \u003Cb>Note:\u003C\u002Fb> This filing is an intimation of the call and does not contain any financial results.",{"company_name":478,"filing_date":528,"filing_source":34,"headline":529,"id":530,"stock_code":153,"summary_text":531},"2026-04-23T21:13:48.486000","To Split into 3 Listed Entities","69ea3e769488adfc758f470f","*   The Board has given in-principle approval for a major demerger, planning to trifurcate (split) the company into three separate entities.\n*   This action is driven by a Family Settlement Agreement among the promoter (Todi) family to divide the business and ensure long-term harmony.\n*   The existing company (Lux Industries Ltd) will continue to be listed, and two new companies will be created and subsequently listed on the stock exchanges.\n*   Each of the three companies will be managed independently by a different branch of the Todi family, with specific brands (e.g., Lux Cozi, Lux Venus, Lux Classic) and manufacturing facilities allocated to each.\n*   The demerger is subject to regulatory and shareholder approvals. Existing shareholders will likely receive shares in the two new companies as part of the scheme.",{"company_name":478,"filing_date":533,"filing_source":34,"headline":534,"id":535,"stock_code":153,"summary_text":536},"2026-04-23T21:08:49.318000","Announces Demerger to Split Business into Three Listed Entities","69ea3d57548b379cc051b16d","*   The Board has approved a demerger to split the company into three separate, listed entities, following a Family Settlement Agreement among the promoters.\n*   The existing company, Lux Industries Ltd., will continue as one of the three entities, managed by the PKT Family (led by Shri Pradip Kumar Todi), and will retain brands like Lux Venus and Lyra.\n*   Two new companies will be formed and listed. One will be managed by the AKT Family (with brands like Lux Cozi, ONN) and the other by the KKT Family (with brands like GenX, Lux Classic).\n*   Existing shareholders will receive shares in the two new resulting companies, effectively splitting their investment across three distinct businesses.\n*   The AKT and KKT families will no longer be involved in the management of the demerged Lux Industries Ltd.",{"company_name":149,"filing_date":538,"filing_source":9,"headline":539,"id":540,"stock_code":153,"summary_text":541},"2026-04-23T21:08:47.960000","Major Shake-up: Lux Industries to Trifurcate Following Family Settlement","69ea3d561248469de897054c","* The Board has given in-principle approval for a demerger to split the company's business into three separate verticals (Vertical A, B, and C).\n* This major restructuring is driven by a Family Settlement Agreement among the promoter (Todi) family.\n* Each vertical, with its own set of brands and manufacturing units, will be managed and controlled by a different branch of the promoter family.\n* The businesses of Vertical A and Vertical C will be demerged into two new companies that will be separately listed on the stock exchanges. Vertical B will remain with the existing listed entity, Lux Industries Limited.\n* Existing shareholders are expected to receive shares in the two new listed companies in addition to their current holdings in Lux Industries Ltd.",{"company_name":543,"filing_date":544,"filing_source":9,"headline":545,"id":546,"stock_code":547,"summary_text":548},"Mahindra & Mahindra Financial Services Limited","2026-04-23T21:03:48.865000","Successfully Redeems ₹350 Crore in Commercial Papers","69ea3c07cc135cc3c597063c","M&MFIN","*   The company has fulfilled its payment obligation by redeeming a series of Commercial Papers (CPs) that matured on April 23, 2026.\n*   The total amount redeemed was ₹350 Crore, with the outstanding amount for this specific series (ISIN: INE774D14T12) now being nil.\n*   This timely redemption of a significant debt obligation is a positive signal, demonstrating strong liquidity management and financial discipline.",{"company_name":142,"filing_date":550,"filing_source":9,"headline":551,"id":552,"stock_code":146,"summary_text":553},"2026-04-23T21:03:48.758000","Board Approves ₹450 Cr Equity Raise & New ₹160 Cr Project","69ea3c1c83759b4678fe92a5","*   The Board has approved raising up to **₹450 Crore** through a preferential issue of equity shares to promoters and institutional investors at a price of ₹483 per share.\n*   An enabling approval was also given to raise up to **₹200 Crore** by issuing Non-Convertible Debentures (NCDs).\n*   A new **Gypsum Processing Plant** will be established with an estimated cost of **₹160 Crore**, aimed at monetizing a by-product from the PLA project.\n*   The capital outlay for the ongoing **Poly Lactic Acid (PLA) project has been revised upwards by ₹230 Crore** to a new total of ₹3,080 Crore due to cost escalations.\n*   An Extra-Ordinary General Meeting (EGM) is scheduled for **May 20, 2026**, to seek shareholder approval for the preferential issue.",{"company_name":555,"filing_date":556,"filing_source":9,"headline":557,"id":558,"stock_code":559,"summary_text":560},"Power Grid Corporation of India Limited","2026-04-23T21:03:48.647000","Confirms Timely Interest & Principal Payment on Bonds","69ea3c065f912cbbc08f44ff","POWERGRID","• The company has made timely payment of interest and a scheduled partial redemption for its 7.55% POWERGRID Bond LXXVII Issue (ISIN: INE752E08742).\n• **Interest Paid:** A total of ₹ 203.85 Crore was paid on the due date of April 23, 2026.\n• **Principal Redeemed:** A partial redemption of ₹ 300 Crore was completed as scheduled.\n• **Outstanding Balance:** The outstanding principal on this bond series is now reduced to ₹ 2,400 Crore.\n• This action demonstrates strong financial discipline and fulfills compliance requirements under SEBI regulations.",{"company_name":218,"filing_date":562,"filing_source":9,"headline":563,"id":564,"stock_code":222,"summary_text":565},"2026-04-23T21:03:48.529000","Issues New Shares Under Employee Stock Option Plan","69ea3bff6a5edce36d8f45f5","*   Allotted 129,573 new equity shares to employees upon the exercise of stock options (ESOP).\n*   The company's total paid-up share capital has increased from 152,231,365 to 152,360,938 shares.\n*   This results in a minor equity dilution of approximately 0.085% for existing shareholders.",{"company_name":567,"filing_date":568,"filing_source":9,"headline":569,"id":570,"stock_code":571,"summary_text":572},"Muthoot Capital Services Limited","2026-04-23T21:03:48.523000","New Head of Collections Appointed to Strengthen Recoveries","69ea3bfb60e6549cbc51af79","MUTHOOTCAP","*   Mr. Sooraj Mohan has resigned as Head - Collections, effective April 23, 2026.\n*   Mr. Vinay B N has been appointed as the new Head - Collections and Recoveries, effective April 24, 2026, ensuring a swift leadership transition.\n*   The new appointee brings over 24 years of experience in collections and recoveries, with his last role at Toyota Financial Services.\n*   This strategic appointment is seen as an effort to strengthen the company's asset quality management, a critical function for an NBFC.",{"company_name":574,"filing_date":575,"filing_source":9,"headline":576,"id":577,"stock_code":578,"summary_text":579},"FORCE MOTORS LTD","2026-04-23T21:03:48.318000","Finalizes ₹161.96 Cr Acquisition of Veera Tanneries","69ea3bff9488adfc758f46ff","FORCEMOT","- The company has completed the acquisition of Veera Tanneries Private Limited (“VTPL”) for a total value of ₹161.96 Crores.\n- This transaction was executed via a Share Purchase Agreement on April 23, 2026, and is now complete.\n- The strategic fit of an auto manufacturer acquiring a tannery business is not immediately clear, suggesting a potential diversification or vertical integration play that warrants further scrutiny by investors.",{"company_name":581,"filing_date":582,"filing_source":9,"headline":583,"id":584,"stock_code":585,"summary_text":586},"Shilpa Medicare Limited","2026-04-23T21:03:48.263000","Appoints New Chief Operating Officer to Strengthen Operations","69ea3c1f548b379cc051b166","SHILPAMED","*   The company has appointed Dr. Vellaian Karuppiah as its new Chief Operating Officer (COO), effective April 23, 2026.\n*   Dr. Karuppiah brings over 33 years of pharmaceutical experience, having held senior leadership roles at major firms like Gland Pharma and Dr. Reddy’s Laboratories.\n*   This strategic appointment is intended to significantly strengthen the company's Formulation business, enhance operational efficiencies, and support long-term sustainable growth.\n*   The move is considered a material positive development for shareholders, signaling a strong focus on improving operational performance and driving value.",{"company_name":588,"filing_date":589,"filing_source":9,"headline":590,"id":591,"stock_code":592,"summary_text":593},"Britannia Industries Limited","2026-04-23T21:03:48.216000","Britannia Announces Key Leadership Change in HR","69ea3bff373ff94e07fe90c5","BRITANNIA","*   \u003Cb>Resignation:\u003C\u002Fb> Mr. Ritesh Rana has resigned as Vice President - Human Resources, effective 15 May 2026.\n*   \u003Cb>Appointment:\u003C\u002Fb> Mr. Srinivas Maruthi Patnam has been appointed as the new Vice President - Human Resources.\n*   \u003Cb>New Appointee's Background:\u003C\u002Fb> Mr. Patnam brings approximately 26 years of experience, previously serving as the VP & HR Head for Procter & Gamble (P&G) India and as a Board Member of Gillette India.\n*   \u003Cb>Significance:\u003C\u002Fb> This is a strategic leadership transition, replacing the outgoing VP with a highly experienced professional from a leading global FMCG company.",{"company_name":595,"filing_date":596,"filing_source":9,"headline":597,"id":598,"stock_code":34,"summary_text":599},"BSE Limited","2026-04-23T20:58:49.299000","BSE Announces Merger of Its Wholly-Owned Subsidiaries","69ea3add548b379cc051b15f","*   BSE is merging two of its wholly-owned subsidiaries, **BSE Investments Ltd.** and **BSE Administration & Supervision Ltd.**, into a third subsidiary, **BSE Technologies Private Ltd.**\n*   The primary goal is to **simplify the corporate structure**, improve efficiency, and reduce administrative costs.\n*   The merger will be executed via a share swap with no cash consideration. BSE Technologies will issue **27.74 crore new shares** to the parent company, BSE Ltd.\n*   This is an internal group restructuring and is not expected to have a direct cash or dilution impact on the public shareholders of BSE Limited.",{"company_name":567,"filing_date":601,"filing_source":9,"headline":602,"id":603,"stock_code":571,"summary_text":604},"2026-04-23T20:53:50.709000","Announces Key Leadership Change in Collections & Recoveries","69ea39a941a709c546fe91ab","• \u003Cb>Cessation:\u003C\u002Fb> Mr. Sooraj Mohan has resigned from the post of 'Head - Collections', effective April 23, 2026.\n• \u003Cb>Appointment:\u003C\u002Fb> Mr. Vinay B N has been appointed as the new 'Head - Collections and Recoveries', effective April 24, 2026.\n• \u003Cb>New Appointee Profile:\u003C\u002Fb> Mr. Vinay is a seasoned professional with over 24 years of experience, with his last role at Toyota Financial Services India Limited.\n• \u003Cb>Strategic Implication:\u003C\u002Fb> This change in a critical role suggests a strategic focus on strengthening the company's asset quality and recovery functions.",true,100,1,1256]